Olmesartan Drug Interactions
- Benicar
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
About Olmesartan
Olmesartan is an angiotensin II receptor antagonist used to treat high blood pressure in adults and children.
Read the full Olmesartan drug information pageQuick links
The Bottom Line on Olmesartan
Olmesartan's interactions most often show up as blood pressure changes, so you might feel dizzy, lightheaded or faint, and the kidneys can be affected too. It is a blood pressure medicine that works by relaxing and widening your blood vessels, and it is used in adults and children.
It has about as many documented interactions as a typical medicine, and some of them are rated serious. Lisinopril is one of them: taken together, the two can cause low blood pressure, fainting, high potassium and changes in how the kidneys work. If you notice anything new after starting something else alongside olmesartan, tell your pharmacist or doctor.
From the HelloPharmacist Editorial Team Written with AI from this page's interaction records · How we build these pages · How we use AI · Our editorial policy
Check Olmesartan Against Another Drug or Supplement
Type a drug, a brand name or a supplement. We check it against every documented olmesartan interaction, supplements and herbs included.
What Could Happen When Olmesartan Interacts
What the 98 documented olmesartan interaction records say could happen, grouped by the problem each one names. Tap a bar to see those drugs.
This chart covers drug interactions only. Interactions with supplements and herbs are studied far less, so they are not counted here; they have their own pages on this site. One interaction can name more than one problem, so the numbers add up to more than 98.
Olmesartan Interactions by Severity
Moderate
- Olmesartan and Asenapine Transdermal Patch Explained Brand names: Secuado, Saphris An increased risk of hypotension Details
- Olmesartan and Bromfenac Ophthalmic Explained Brand names: Bromsite, Prolensa, Bromday Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details
- Olmesartan and Diclofenac Ophthalmic Explained Brand names: Voltaren Eye, Zorvolex, Pennsaid Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details
- Olmesartan and Diclofenac Topical (Actinic Keratosis) Explained Brand names: Solaraze Gel, Zorvolex, Pennsaid Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details
- Olmesartan and Diclofenac Topical (Arthritis Pain) Explained Brand names: Pennsaid, Voltaren Arthritis Pain, Zorvolex Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details
- Olmesartan and Diclofenac Transdermal Patch Explained Brand names: Flector Patch, Licart Topical System, Zorvolex Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details
- Olmesartan and Etodolac Explained Brand names: Lodine, Lodine XL Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details
- Olmesartan and Fenoprofen Explained Brand names: Nalfon, Fenopron Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details
- Olmesartan and Flurbiprofen Explained Brand names: Ansaid, Ocufen, Lurbipr Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details
- Olmesartan and Flurbiprofen Ophthalmic Explained Brand names: Ocufen, Ansaid, Lurbipr Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details
- Olmesartan and Ibuprofen Explained Brand names: Advil, Midol, Motrin Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details
- Olmesartan and Insulin Degludec (rDNA Origin) Injection Explained Brand name: Tresiba Increased risk of hypoglycemia Details
- Olmesartan and Insulin Detemir (rDNA Origin) Injection Explained Brand name: Levemir Increased risk of hypoglycemia Details
- Olmesartan and Insulin Glulisine (rDNA Origin) Injection Explained Brand names: Apidra, Apidra SoloStar Increased risk of hypoglycemia Details
- Olmesartan and Ketoprofen Explained Brand names: Actron, Nexcede, Orudis Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details
- Olmesartan and Ketorolac Explained Brand names: Toradol, Sprix, Acuvail Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details
- Olmesartan and Ketorolac Injection Explained Brand names: Toradol, Sprix, Acuvail Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details
- Olmesartan and Ketorolac Nasal Spray Explained Brand names: Sprix, Acuvail, Acular Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details
- Olmesartan and Ketorolac Ophthalmic Explained Brand names: Acular, Acuvail, Sprix Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details
- Olmesartan and Meclofenamate Explained Brand names: Meclodium, Meclomen Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details
Look Up Another Drug
Still Have Questions About Olmesartan?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
The References Behind Olmesartan’s Interactions
The 98 sources our olmesartan interaction records cite: clinical studies, case reports and FDA prescribing information. Each pair's page lists the ones it rests on, numbered in its text, and a source link is one we checked against PubMed or Crossref. How we check them →
- Haller H, Ito S, Izzo JL Jr, et al: Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med 2011; 364(10):907-917.
- Imai E, Chan JC, Ito S, et al: Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study. Diabetologia 2011; 54(12):2978-2986. PubMed
- Jones DW, Ferdinand KC, Taler SJ, et al: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM guideline for the prevention, detection, evaluation and management of high blood pressure in adults. Circulation 2025; 152(11):e114-e218.
- Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013; 3(1):1-150.
- Product Information: BENICAR(R) oral tablets, olmesartan medoxomil oral tablets. Daiichi Sankyo (per FDA), Basking Ridge, NJ, 2019. DailyMed
- Product Information: BENICAR(R) oral tablets, olmesartan medoxomil oral tablets. Daiichi Sankyo (per manufacturer), Basking Ridge, NJ, 2017. DailyMed
- Izzo JL, Neutel JM, Silfani T, et al: Efficacy and safety of treating stage 2 systolic hypertension with olmesartan and olmesartan/HCTZ: results of an open-label titration study. J Clin Hypertens 2007; 9(1):36-44. PubMed
- Barrios V, Boccanelli A, Ewald S, et al: Efficacy and tolerability of olmesartan medoxomil in patients with mild to moderate essential hypertension: the OLMEBEST Study. Clin Drug Investig 2007; 27(8):545-558. DOI
- de la Sierra A, Armario P, Oliveras A, et al: Antihypertensive drug use in resistant and nonresistant hypertension and in controlled and uncontrolled resistant hypertension. J Hypertens 2018; 36(7):1563-1570. PubMed
- Sakata Y, Shiba N, Takahashi J, et al: Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial. Eur Heart J 2015; 36(15):915-923.